Author(s):
P. Pavani, E. Naveena, P. Subhashini, S. Srikanth, K. Thirumala Naik, M. Kishore Babu
Email(s):
pavanichowdary.para1196@gmail.com.
DOI:
10.52711/2321-5836.2022.00046 
Address:
P. Pavani1*, E. Naveena2, P. Subhashini2, S. Srikanth2, K. Thirumala Naik3, M. Kishore Babu4
1Pharm D, Krishna Teja Pharmacy College, Tirupati, Andhra Pradesh.
2Pharm D, Krishna Teja Pharmacy College, Tirupati, Andhra Pradesh.
3Associate Professor, Krishna Teja Pharmacy College, Tirupati, Andhra Pradesh.
4Principal, Krishna Teja Pharmacy College, Tirupati, Andhra Pradesh.
*Corresponding Author
Published In:
Volume - 14,
Issue - 4,
Year - 2022
ABSTRACT:
Non-Steroidal Anti-inflammatory Drugs (NSAIDs) are used as over-the-counter drugs for Analgesic and Anti-inflammatory conditions. They inhibit prostaglandins synthesis by acting on Cyclooxygenase enzymes in the Arachidonic cascade which causes various abnormal effects like peptic ulcers, Gastrointestinal bleeding, sodium and water retention, hypertension, hemodynamic kidney injury, nephrotoxicity, stroke, and myocardial infarction when used for a longer duration, especially in older patients/comorbidities patients/ pre-existing renal disease patients. This is because in older patients decrease in glomerular filtration rate and comorbidity conditions increase the risk of NSAIDs and cause Acute Kidney injury, Tubulointerstitial nephritis, and chronic kidney injury. NSAIDs do not cause much risk in patients who are young, without pre-existing kidney disease and without comorbidities. Physicians should educate patients with caution on the usage of NSAIDs for longer periods and should prescribe drugs in a dose-dependent manner.
Cite this article:
P. Pavani, E. Naveena, P. Subhashini, S. Srikanth, K. Thirumala Naik, M. Kishore Babu. A Review on Non-Steroidal Anti-Inflammatory Drugs Induced Kidney Diseases. Research Journal of Pharmacology and Pharmacodynamics.2022;14(4):268-2. doi: 10.52711/2321-5836.2022.00046
Cite(Electronic):
P. Pavani, E. Naveena, P. Subhashini, S. Srikanth, K. Thirumala Naik, M. Kishore Babu. A Review on Non-Steroidal Anti-Inflammatory Drugs Induced Kidney Diseases. Research Journal of Pharmacology and Pharmacodynamics.2022;14(4):268-2. doi: 10.52711/2321-5836.2022.00046 Available on: https://rjppd.org/AbstractView.aspx?PID=2022-14-4-12
REFERENCES:
1. Drożdżal, S., Lechowicz, K., Szostak, B., Rosik, J., Kotfis, K., Machoy-Mokrzyńska, A., Białecka, M., Ciechanowski, K., and Gawrońska-Szklarz, B. (2021). Kidney damage from nonsteroidal anti-inflammatory drugs-Myth or truth? Review of selected literature. Pharmacology research and perspectives, 9(4), e00817. https://doi.org/10.1002/prp2.817.
2. Clavé, S., Rousset-Rouvière, C., Daniel, L., and Tsimaratos, M. (2019). The Invisible Threat of Non-steroidal Anti-inflammatory Drugs for Kidneys. Frontiers in pediatrics, 7, 520. https://doi.org/10.3389/fped.2019.00520.
3. Fokunang, Charles. (2018). Overview of non-steroidal anti-inflammatory drugs (nsaids) in resource limited countries. MOJ Toxicology. 4. 10.15406/mojt.2018.04.00081.
5. Lucas, G., Leitão, A., Alencar, R. L., Xavier, R., Daher, E. F., and Silva Junior, G. (2019). Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia, 41(1), 124–130. https://doi.org/10.1590/2175-8239-JBN-2018-0107.
6. Keen MU, Aeddula NR. Analgesic Nephropathy. [Updated 2022 Jan 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-.
7. Gunaydin, C., and Bilge, S. S. (2018). Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level. The Eurasian journal of medicine, 50(2), 116–121. https://doi.org/10.5152/eurasianjmed.2018.0010.
8. Hsu, C. C., Wang, H., Hsu, Y. H., Chuang, S. Y., Huang, Y. W., Chang, Y. K., Liu, J. S., Hsiung, C. A., and Tsai, H. J. (2015). Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Chronic Kidney Disease in Subjects with Hypertension: Nationwide Longitudinal Cohort Study. Hypertension (Dallas, Tex.: 1979), 66(3), 524–533. https://doi.org/10.1161/HYPERTENSIONAHA.114.05105 .
9. Ejaz, P., Bhojani, K., and Joshi, V. R. (2004). NSAIDs and kidney. The Journal of the Association of Physicians of India, 52, 632–640.
10. Hayashi, K., Miki, K., Kajiyama, H., Ikemoto, T., and Yukioka, M. (2021). Impact of Non-steroidal Anti-inflammatory Drug Administration for 12 Months on Renal Function. Frontiers in pain research (Lausanne, Switzerland), 2, 644391. https://doi.org/10.3389/fpain.2021.644391.
11. Sabatino D, Tillman M, Pawasauskas J, Brothers T. (2020) Nonsteroidal anti-inflammatory drug induced acute kidney injury, A review and case study. J Renal Inj Prev. 2020; 9(4): e34. doi: 10.34172/jrip.2020.34.
12. Whelton, A., and Hamilton, C. W. (1991). Nonsteroidal anti-inflammatory drugs: effects on kidney function. Journal of clinical pharmacology, 31(7), 588–598. https://doi.org/10.1002/j.1552-4604.1991.tb03743.x.
13. Medsafe; Newzealand medicines and medical devices, safety authority. june 2013,34(2);14-15.
14. Dixit, M., Doan, T., Kirschner, R., and Dixit, N. (2010). Significant Acute Kidney Injury Due to Non-steroidal Anti-inflammatory Drugs: Inpatient Setting. Pharmaceuticals (Basel, Switzerland), 3(4), 1279–1285. https://doi.org/10.3390/ph3041279.
15. Joyce, E., Glasner, P., Ranganathan, S., and Swiatecka-Urban, A. (2017). Tubulointerstitial nephritis: diagnosis, treatment, and monitoring. Pediatric nephrology (Berlin, Germany), 32(4), 577–587. https://doi.org/10.1007/s00467-016-3394-5.
16. Bensman A. (2020). Non-steroidal Anti-inflammatory Drugs (NSAIDs) Systemic Use: The Risk of Renal Failure. Frontiers in pediatrics, 7, 517. https://doi.org/10.3389/fped.2019.00517.
17. Zhang, X., Donnan, P. T., Bell, S., and Guthrie, B. (2017). Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis. BMC nephrology, 18(1), 256. https://doi.org/10.1186/s12882-017-0673-8 .
18. Chen, T. K., Knicely, D. H., and Grams, M. E. (2019). Chronic Kidney Disease Diagnosis and Management: A Review. JAMA, 322(13), 1294–1304. https://doi.org/10.1001/jama.2019.14745.
19. Nelson, D. A., Marks, E. S., Deuster, P. A., O'Connor, F. G., and Kurina, L. M. (2019). Association of Nonsteroidal Anti-inflammatory Drug Prescriptions with Kidney Disease Among Active Young and Middle-aged Adults. JAMA network open, 2(2), e187896. https://doi.org/10.1001/jamanetworkopen.2018.7896 .
20. Pai, A. B., Vassalotti, J. A., Fox, C. H., Carroll, J. K., Pulver, G. E., Dickinson, L. M., and Pace, W. D. (2020). Association between NSAID Exposure and Kidney Function Decline in Primary Care Patients. Kidney360, 1(6), 521–523. https://doi.org/10.34067/KID.0001102019 .